Biomedical Solutions Group, Inc.
Search

Biomedical Solutions Group — BMSG, Inc. Management

The management consists of two co-founders and four senior members, who have extensive careers in management, research and clinical works.

Andrew M. Bartkowski, M.D., M.Sc., Exec-MBA.
One of the co-founders of BMSG. Serves as Chief Executive Managing Director. Mr.Bartkowski has managed the foreign subsidiary of Fibrin Corporation in Poland. He has years of experience in soliciting participation in commercial joint-venture for clinical evaluation and production of the tissue sealants and other biotech products. In the USA, he worked with, and was a business associate of the late Professor John F.Lontz, who was one of the inventors ( at DuPont Co.) of the widely used Teflon. Since 2002, responsible for international relations at BMSG. Member of the Board of Directors.

Zbigniew Dabczewski, Ph.D.,Emeritius Professor of Genetics and Veterinary Medicine.
One of the co-founders of BMSG and, at the same time, one of the very few pioneers of medical and veterinary genetics in Poland. Over the period of 20 years, he was working as a professional consultant at the United Nations in more than 20 different countries worldwide. Recognized as expert at the BESO-British Executives Service Overseas. He used to work as a consultant for different governments. Serves as a Honorary CEO at BMSG. Member of the Board of Directors.

Wlod. Maslinski, PhD, Professor of Medicine.
Head, Department of Immunology at the Institute of Rheumatology in Warsaw, Poland. Recognized expert on clinical immunology. In the USA, he worked with Professor T.Strom at the Beth Israel Deaconess Medical Center, Harvard Medical School, between 1989-1997. He is currently at the Institute of Rheumatology in Warsaw. The major focus of his work has been on Interleukins ( IL-15) and biomaterials used in clinical medicine. Together with Prof.T.Wierzchon, he works on new generation of new titanium biomaterials and its clinical applications in medicine. Member of the Board of Directors.

Artur H.Swiergiel, DVM, PhD in Behavioral Pharmacology and Physiology from the University of Cambridge, UK.
Currently Professor of Pharmacology at the Louisiana University Health Sciences Center. Expert in the behavioral and physiological characterization of genetically modified animals and animal models (anxiety, depression, eating disorders, obesity, etc.) The major focus of his work has been on the neurophysiological and molecular mechanisms underlying behavioral disorders.

Richard Slomski,Ph.D., Professor of Genetics and Molecular Biology.
Recognized expert on molecular and diagnostic genetics. Executive member of the Polish Academy of Sciences. His area of interest includes molecular diagnostics, molecular basis of inherited diseases, multifactorial genetic disorders and biotechnology. Over the past few years, prepares genetic inserts, which we use for breeding of genetically modified animals, including transgenic rabbits and transgenic pigs. Member of the Board of Directors.

Z.Smorag, PhD, Professor of Veterinary Medicine.
Recognized expert in animal reproduction. Over the past ten years, he focused his work on transgenetic animal research. He is currently at the National Institute of Animal Reproduction in Krakow, Poland. Executive Member of the Polish Academy of Sciences. Together with Prof. R.Slomski, works on breeding of genetically modified animals, including transgenic pigs and xenotransplantation project with new applications in medicine. Member of the Board of Directors.

Copyright 2018 © Biomedical Solutions Group, Inc. projektowanie stron www Reserved. © Chicago Web Design